Trial
NCT06321562
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
EyeD Pharma
Collaborators
—
Condition
Primary Open-angle Glaucoma
Intervention
TimoD implant
Why stopped
The study was terminated early due to the difficulties to enrol participant
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-16